Closing date: 
Sunday, April 14, 2019
A short description of the information call.

Advancing Healthcare Innovation Africa (AHIA) is now accepting applications from African healthcare innovators for the 2019 conference in Johannesburg. 

 

 

The UCT invention describes a method and point of care test for diagnosing symptomatic and asymptomatic sexually transmitted infections (STIs) and bacterial vaginosis (BV). STIs and BV cause inflammation in the female genital tract. In resource-limited settings, BV and STIs are managed according...

Plant Produced Biologics Cape Bio Pharms (CBP) is an exciting company to commercialise the biotechnology developed by the Biopharming Research Unit at UCT. CBP's aim is to develop a world-class commercial-scale capability in RSA for the production of patented plant-produced enzymes, diagnostic...

We have developed a technology, which relates to an enriched extract and single active compound from rooibos tea. This compound has a demonstrable effect against a variety of metabolic disorders, a major worldwide health threat. The SAMRC has generated substantial in vitro and in vivo data on...

Medical 3D Printing Pipeline The University of Cape Town's (UCT) Division of Biomedical Engineering (UCT BME) strives to create cost effective designs and use innovative materials to ‘3D print’ medical devices, especially with the aim of solving unmet clinical needs identified. UCT has the...

The Sports Injury GeneScreen is a non-diagnostic DNA test consisting of eight DNA sequence variants within five clinically useful genes associated with the risk of sustaining common tendon and ligament injuries. The genetic test is performed in conjunction with a physical activity history and a...

Copyright © Innovation Bridge 2019 All rights reserved.